Evidence map›Paper›PMID 32015106›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Hsp47 promotes cancer metastasis by enhancing collagen-dependent cancer cell-platelet interaction.

Gaofeng Xiong, Jie Chen, Guoying Zhang, Shike Wang, Kunito Kawasaki, Jieqing Zhu, Yan Zhang, Kazuhiro Nagata, Zhenyu Li, Binhua P Zhou and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 137 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. The Duality of Collagens in Metastases of Solid Tumors.International journal of molecular sciences · 2025
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Gaofeng XiongMarkey Cancer Center, University of Kentucky, Lexington, KY 40536.
Jie ChenMarkey Cancer Center, University of Kentucky, Lexington, KY 40536.
Guoying ZhangDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Kentucky, Lexington, KY 40536.
Shike WangMarkey Cancer Center, University of Kentucky, Lexington, KY 40536.
Kunito KawasakiDepartment of Molecular and Cellular Biology, Kyoto Sangyo University, Kyoto 603-8555, Japan.
Jieqing ZhuMarkey Cancer Center, University of Kentucky, Lexington, KY 40536.
Yan ZhangDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Kentucky, Lexington, KY 40536.
Kazuhiro NagataDepartment of Molecular and Cellular Biology, Kyoto Sangyo University, Kyoto 603-8555, Japan.
Zhenyu LiDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Kentucky, Lexington, KY 40536.
Binhua P ZhouMarkey Cancer Center, University of Kentucky, Lexington, KY 40536.
Ren XuMarkey Cancer Center, University of Kentucky, Lexington, KY 40536; ren.xu2010@uky.edu.ORCID 0000-0002-3591-9522
University of Kentucky · USKyoto Sangyo University · JP

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers · 2013 to 2026
$38.3M
Roles of Hsp47 in Breast Cancer ProgressionR01CA207772 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI XU, REN · 2017 to 2025
$3.1M
Roles of RORalpha in breast cancer development and progressionR01CA215095 · NCI · UNIVERSITY OF KENTUCKY · PI XU, REN · 2017 to 2022
$1.7M
Systemic delivery of miR-29 for basal-like breast cancer treatmentR21CA209045 · NCI · UNIVERSITY OF KENTUCKY · PI SHU, DAN, XU, REN · 2016 to 2017
$375k
NCI NIH HHS P30 CA177558NCI NIH HHS R01 CA207772NCI NIH HHS R01 CA215095NCI NIH HHS R21 CA209045
6 · The paper itself

Abstract

Increased expression of extracellular matrix (ECM) proteins in circulating tumor cells (CTCs) suggests potential function of cancer cell-produced ECM in initiation of cancer cell colonization. Here, we showed that collagen and heat shock protein 47 (Hsp47), a chaperone facilitating collagen secretion and deposition, were highly expressed during the epithelial-mesenchymal transition (EMT) and in CTCs. Hsp47 expression induced mesenchymal phenotypes in mammary epithelial cells (MECs), enhanced platelet recruitment, and promoted lung retention and colonization of cancer cells. Platelet depletion in vivo abolished Hsp47-induced cancer cell retention in the lung, suggesting that Hsp47 promotes cancer cell colonization by enhancing cancer cell-platelet interaction. Using rescue experiments and functional blocking antibodies, we identified type I collagen as the key mediator of Hsp47-induced cancer cell-platelet interaction. We also found that Hsp47-dependent collagen deposition and platelet recruitment facilitated cancer cell clustering and extravasation in vitro. By analyzing DNA/RNA sequencing data generated from human breast cancer tissues, we showed that gene amplification and increased expression of Hsp47 were associated with cancer metastasis. These results suggest that targeting the Hsp47/collagen axis is a promising strategy to block cancer cell-platelet interaction and cancer colonization in secondary organs.

Indexed as

AnimalsBlood PlateletsBreast NeoplasmsCollagenEpithelial-Mesenchymal TransitionExtracellular MatrixFemaleGene AmplificationHSP47 Heat-Shock ProteinsHumansMice, SCIDNeoplasm MetastasisNeoplastic Cells, CirculatingCollagenHSP47 Heat-Shock Proteinsbreast cancercancer metastasiscirculating tumor cellepithelial-mesenchymal transitionextracellular matrix

Identifiers

PMID32015106
PMCPMC7035603
OpenAlexW3004443732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.